Emergent Biosolutions Inc.‘s (EBS) share price has entered into oversold territory with a stochastic value of 9.978. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased a cent over the past month to 65 cents per share. Emergent Biosolutions Inc. is a Zacks #1 Rank (” Strong Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
